TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion

Abstract Background Glioblastoma multiforme (GBM) is characterized by lethal aggressiveness and patients with GBM are in urgent need for new therapeutic avenues to improve quality of life. Current studies on tumor invasion focused on roles of cytokines in tumor microenvironment and numerous evidence...

Full description

Bibliographic Details
Main Authors: Chao Zhang, Xin Zhang, Ran Xu, Bin Huang, An-Jing Chen, Chao Li, Jian Wang, Xin-Gang Li
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-017-0628-8
_version_ 1828392102548996096
author Chao Zhang
Xin Zhang
Ran Xu
Bin Huang
An-Jing Chen
Chao Li
Jian Wang
Xin-Gang Li
author_facet Chao Zhang
Xin Zhang
Ran Xu
Bin Huang
An-Jing Chen
Chao Li
Jian Wang
Xin-Gang Li
author_sort Chao Zhang
collection DOAJ
description Abstract Background Glioblastoma multiforme (GBM) is characterized by lethal aggressiveness and patients with GBM are in urgent need for new therapeutic avenues to improve quality of life. Current studies on tumor invasion focused on roles of cytokines in tumor microenvironment and numerous evidence suggests that TGF-β2 is abundant in glioma microenvironment and vital for glioma invasion. Autopagy is also emerging as a critical factor in aggressive behaviors of cancer cells; however, the relationship between TGF-β2 and autophagy in glioma has been poorly understood. Methods U251, T98 and U87 GBM cell lines as well as GBM cells from a primary human specimen were used in vitro and in vivo to evaluate the effect of TGF-β2 on autophagy. Western blot, qPCR, immunofluorescence and transmission-electron microscope were used to detect target molecular expression. Lentivirus and siRNA vehicle were introduced to establish cell lines, as well as mitotracker and seahorse experiment to study the metabolic process in glioma. Preclinical therapeutic efficacy was evaluated in orthotopic xenograft mouse models. Results Here we demonstrated that TGF-β2 activated autophagy in human glioma cell lines and knockdown of Smad2 or inhibition of c-Jun NH2-terminal kinase, attenuated TGF-β2-induced autophagy. TGF-β2-induced autophagy is important for glioma invasion due to the alteration of epithelial-mesenchymal transition and metabolism conversion, particularly influencing mitochondria trafficking and membrane potential (△Ψm). Autopaghy also initiated a feedback on TGF-β2 in glioma by keeping its autocrine loop and affecting Smad2/3/7 expression. A xenograft model provided additional confirmation on combination of TGF-β inhibitor (Galunisertib) and autophagy inhibitor (CQ) to better “turn off” tumor growth. Conclusion Our findings elucidated a potential mechanism of autophagy-associated glioma invasion that TGF-β2 could initiate autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion.
first_indexed 2024-12-10T07:15:37Z
format Article
id doaj.art-5a76c273bcbf48aba9bc15082fe5002b
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-10T07:15:37Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-5a76c273bcbf48aba9bc15082fe5002b2022-12-22T01:57:57ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662017-11-0136111510.1186/s13046-017-0628-8TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasionChao Zhang0Xin Zhang1Ran Xu2Bin Huang3An-Jing Chen4Chao Li5Jian Wang6Xin-Gang Li7Department of Neurosurgery, Qilu Hospital of Shandong UniversityDepartment of Neurosurgery, Qilu Hospital of Shandong UniversityDepartment of Neurosurgery, Qilu Hospital of Shandong UniversityBrain Science Research Institute, Shandong UniversityBrain Science Research Institute, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital of Shandong UniversityDepartment of Neurosurgery, Qilu Hospital of Shandong UniversityDepartment of Neurosurgery, Qilu Hospital of Shandong UniversityAbstract Background Glioblastoma multiforme (GBM) is characterized by lethal aggressiveness and patients with GBM are in urgent need for new therapeutic avenues to improve quality of life. Current studies on tumor invasion focused on roles of cytokines in tumor microenvironment and numerous evidence suggests that TGF-β2 is abundant in glioma microenvironment and vital for glioma invasion. Autopagy is also emerging as a critical factor in aggressive behaviors of cancer cells; however, the relationship between TGF-β2 and autophagy in glioma has been poorly understood. Methods U251, T98 and U87 GBM cell lines as well as GBM cells from a primary human specimen were used in vitro and in vivo to evaluate the effect of TGF-β2 on autophagy. Western blot, qPCR, immunofluorescence and transmission-electron microscope were used to detect target molecular expression. Lentivirus and siRNA vehicle were introduced to establish cell lines, as well as mitotracker and seahorse experiment to study the metabolic process in glioma. Preclinical therapeutic efficacy was evaluated in orthotopic xenograft mouse models. Results Here we demonstrated that TGF-β2 activated autophagy in human glioma cell lines and knockdown of Smad2 or inhibition of c-Jun NH2-terminal kinase, attenuated TGF-β2-induced autophagy. TGF-β2-induced autophagy is important for glioma invasion due to the alteration of epithelial-mesenchymal transition and metabolism conversion, particularly influencing mitochondria trafficking and membrane potential (△Ψm). Autopaghy also initiated a feedback on TGF-β2 in glioma by keeping its autocrine loop and affecting Smad2/3/7 expression. A xenograft model provided additional confirmation on combination of TGF-β inhibitor (Galunisertib) and autophagy inhibitor (CQ) to better “turn off” tumor growth. Conclusion Our findings elucidated a potential mechanism of autophagy-associated glioma invasion that TGF-β2 could initiate autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion.http://link.springer.com/article/10.1186/s13046-017-0628-8Malignant brain tumorAutophagyTGF-βTumor invasionGalunisertib
spellingShingle Chao Zhang
Xin Zhang
Ran Xu
Bin Huang
An-Jing Chen
Chao Li
Jian Wang
Xin-Gang Li
TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
Journal of Experimental & Clinical Cancer Research
Malignant brain tumor
Autophagy
TGF-β
Tumor invasion
Galunisertib
title TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
title_full TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
title_fullStr TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
title_full_unstemmed TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
title_short TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
title_sort tgf β2 initiates autophagy via smad and non smad pathway to promote glioma cells invasion
topic Malignant brain tumor
Autophagy
TGF-β
Tumor invasion
Galunisertib
url http://link.springer.com/article/10.1186/s13046-017-0628-8
work_keys_str_mv AT chaozhang tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT xinzhang tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT ranxu tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT binhuang tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT anjingchen tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT chaoli tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT jianwang tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion
AT xingangli tgfb2initiatesautophagyviasmadandnonsmadpathwaytopromotegliomacellsinvasion